Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06463769
Other study ID # CRC1697-C04
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2025
Est. completion date July 2028

Study information

Verified date June 2024
Source University of Kiel
Contact Anja Bosy-Westphal, PhD, MD
Phone +494318805674
Email abosyw@nutrition.uni-kiel.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Habitual adherence to a predominantly plant-based diet, rich in low-processed food (LPF) has been associated with a reduced risk for development and slower progression of Parkinson's Disease (PD). This could be due to neuroprotective effects by modulation of the gut microbiota and decreased neuronal and metabolic inflammation. So far, the effect of a predominantly plant-based LPF-diet on the microbiome-immune-brain axis in patients with PD remains unknown. In addition, the influence of dietetic measures on the gut microbiome is variable and may depend on (long-term) adherence as well as on PD-specific factors and lifestyle. The investigators hypothesize that compared to an average German diet, the predominantly plant-based New Nordic LPF-diet, as a culturally adapted diet, which is rich in fermentable fiber and phytochemicals, will have beneficial effects on the gut microbiome of patients with PD by increasing the abundance of short-chain fatty acid (SCFA)-producing bacteria (primary outcome) and will improve gut motility, metabolic resilience, and inflammation (secondary outcomes). Furthermore, the investigators postulate that a patient-centered dietary intervention program, including a multifaceted patient education and supported by a web-application, will lead to high adherence as a key determinant of long-term changes in the gut microbiome. This dietary intervention will be accepted by patients as a low-threshold treatment that balances personal benefits, therapeutic barriers and ethical concerns of early risk disclosure in PD.


Description:

In a pilot-intervention study, our project will: - develop a practical, low-threshold diet intervention for patients with prodromal and clinical PD. Adherence will be promoted (i) by a patient-oriented approach, (ii) by implementation of the predominantly plant-based New Nordic LPF-diet that is scientifically-based, culturally adapted, sustainable and culinary and (iii) by an innovative web-application. - investigate the acute effects of the predominantly plant-based New Nordic LPF -diet on the microbiome (abundance of SCFA-producing bacteria), gastrointestinal motility, inflammation as well as metabolic and Parkinson-specific clinical outcomes in individuals with prodromal and clinical PD. - investigate potential determinants of long-term changes in the gut microbiome (e.g. dietary adherence, gastrointestinal motility, meal timing and frequency), and factors associated with a high adherence (e.g. acceptance of diet as therapeutic intervention in the prodromal phase, health-related quality of life). The patient-centered intervention program will be tailored to individual needs and preferences of individuals with prodromal and clinical PD. It will be designed to impart knowledge (e.g. on sustainability and health effects) and food literacy (e.g. food merchandize and culinary skills) in group meetings and culinary medicine workshops. Recipe suggestions and shopping guides will consider individual abilities and needs and a web-application is used for information, increasing self-efficacy, motivation, and monitoring. To ensure an easy integration of the diet into everyday life, partners will be included in the program, if applicable. Moreover, cultural preferences as well as financial resources will be considered. Regular feedback using statistics on nutrient intake and overall progress will be implemented to encourage adherence.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 75
Est. completion date July 2028
Est. primary completion date December 2027
Accepts healthy volunteers No
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria: - patients with probable prodromal PD (according to predefined criteria) - patients with clinical PD with slight to moderate disease severity (Hoehn & Yahr 1-2.5) - habitual Western Diet (=30% of energy intake from ultra-processed food) Exclusion Criteria: - current adherence to a plant-based diet - food allergies or intolerances - significant diseases of the gastrointestinal system (e.g. celiac disease) or central nervous system, diabetes mellitus - underweight (BMI <18.5 kg/m2) - active smoking - expected changes in medication or antibiotic treatment during the intervention

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
8 week predominantly plant-based New Nordic LPF-diet program
An 8-week patient-centered dietary intervention program will be implemented to maintain a predominantly plant-based New Nordic LPF-Diet.
maintenance of the predominantly plant-based New Nordic LPF-diet
Follow-up of long-term adherence to the diet at one and six months after completion of the intervention program.

Locations

Country Name City State
Germany Institute of Human Nutrition Kiel
Germany Kiel University, University Hospital Schleswig-Holstein Kiel

Sponsors (2)

Lead Sponsor Collaborator
University of Kiel University Hospital Schleswig-Holstein

Country where clinical trial is conducted

Germany, 

References & Publications (3)

Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, Hertzberg V, Auvinen P, Tansey MG, Scheperjans F. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease. Mol Neurodegener. 2021 Feb 8;16(1):6. doi: 10.1186/s13024-021-00427-6. — View Citation

Maraki MI, Yannakoulia M, Stamelou M, Stefanis L, Xiromerisiou G, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, Sakka P, Anastasiou CA, Simopoulou E, Scarmeas N. Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease. Mov Disord. 2019 Jan;34(1):48-57. doi: 10.1002/mds.27489. Epub 2018 Oct 10. — View Citation

Solch RJ, Aigbogun JO, Voyiadjis AG, Talkington GM, Darensbourg RM, O'Connell S, Pickett KM, Perez SR, Maraganore DM. Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review. J Neurol Sci. 2022 Mar 15;434:120166. doi: 10.1016/j.jns.2022.120166. Epub 2022 Jan 26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other clinical motor symptoms clinical examination pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other clinical non-motor symptoms clinical examination pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other gastric emptying 13C-breath test pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other gastrointestinal transit time using a test meal with food colouring and the time to colour appearance in stool pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other gut motility functional visceral MRI pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other dietary adherence via serum markers serum carotinoid and Trimethylamine oxid-levels will be combined and tertiles will be formed pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other dietary adherence via healthy Nordic food Index healthy Nordic food Index using data from a food frequency questionnaire pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other food literacy effectiveness self-perceived food literacy scale (questionnaire) pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other patient acceptance Parkinson's Disease Questionnaire (PDQ-39) pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Other patient quality of life Ways of Coping Questionnaire (WCQ) pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Primary abundance of key SCFA-producing gut bacteria analysis of stool samples pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Secondary systemic inflammation markers hsCRP and IL-6 in serum pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Secondary metabolic resilience modeling of one parameter (metabolic resilience) including information on postprandial glucose, insulin, triglycerides and NEFA following a mixed meal tolerance test pre vs. post intervention (8 weeks)
Secondary gastrointestinal peptide-hormones ghrelin, GLP-1, PYY pre vs. post intervention (8 weeks)
Secondary energy balance changes in body weight pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
Secondary energy partitioning changes in body composition pre vs. post intervention (8 weeks) + pre intervention vs. follow-up 6 months after completion of intervention
See also
  Status Clinical Trial Phase
Completed NCT05415774 - Combined Deep Brain Stimulation in Parkinson's Disease N/A
Recruiting NCT04691661 - Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease Phase 2
Active, not recruiting NCT05754086 - A Multidimensional Study on Articulation Deficits in Parkinsons Disease
Completed NCT04045925 - Feasibility Study of the Taïso Practice in Parkinson's Disease N/A
Recruiting NCT04194762 - PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation N/A
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05830253 - Free-living Monitoring of Parkinson's Disease Using Smart Objects
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT06139965 - Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
Completed NCT04580849 - Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease N/A
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Completed NCT03980418 - Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam N/A
Completed NCT04942392 - Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic N/A
Terminated NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT04997642 - Parkinson's Disease and Movement Disorders Clinical Database
Completed NCT04117737 - A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson N/A
Recruiting NCT03618901 - Rock Steady Boxing vs. Sensory Attention Focused Exercise N/A